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Abstract 
Nutrition may be an important aspect of lung health. Antioxidants, vitamin D, fatty acids, minerals, 
phytochemicals, probiotics and prebiotics, and dietary patterns have been associated with the 
pathophysiology of various lung diseases. Asthma has been related with reduced antioxidant intake and 
omega-3 consumption, while vitamin C has consistently been related to improved pulmonary function. 
Vitamin E supplementation has been associated with lung cancer and should be used with caution in 
smokers. Vitamin D deficiency is common in tuberculosis patients with uncertain benefits as an adjunct 
treatment. The Mediterranean diet and a “healthy” diet pattern are associated with reduced lung cancer 
incidence. Data on phytochemicals and probiotics are encouraging, however, high quality studies are 
generally lacking. 
Keywords: Asthma, Chronic obstructive lung disease, Lung cancer, Cystic fibrosis, Interstitial lung 
disease, Pulmonary function, Lung development, Antioxidants, Vitamins, Minerals, Probiotics, 
Prebiotics, Phytochemicals, Plants, Dietary patterns, Mediterranean diet 
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Introduction 
Hippocrates quote “let food be thy medicine” and thousands of years later we have proofs that nutrition is 
an important aspect of everyday life and a contributor of lung health. Dietary factors may be implicated in 
the pathogenesis, clinical presentation and treatment of various lung diseases, mainly by manipulating 
oxidative stress and lung inflammation.  
Obstructive lung diseases, mainly asthma and chronic obstructive pulmonary disease (COPD), are 
characterized by chronic airway inflammation, and thus diet has increasingly been recognized as a 
potential contributing factor for their presentation. Interestingly, nutrition seems to affect pulmonary 
function and the development of lung diseases in early (or even later) life. Lung cancer is believed to 
result from interplay between genetic and environmental factors, like diet. Unfortunately, data on 
interstitial lung diseases (ILDs) are sparse. 
Although changes in body weight may complicate lung diseases, like asthma or COPD, this chapter will 
focus on the effects of dietary nutrients or dietary patterns in the most common respiratory diseases. For 
more data in that field the reader is referred to comprehensive reviews (Zammit et al. 2010). 
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ASTHMA 
Asthma is a heterogeneous chronic disease characterized by airway inflammation and airway 
hyperresponsiveness to direct or indirect stimuli. Patients with asthma exhibit variable expiratory airflow 
limitation associated with episodic flare-ups (exacerbations) that may be life-threatening. In the same 
context, asthma symptoms, including wheeze, shortness of breath, chest tightness and cough, typically 
vary over time and in intensity. The pathogenesis at asthma is complex and involves airway inflammation 
and enhanced Th-2 responses. In an oversimplified model, (airway inflammation) results in the two 
central components at asthma, i.e. airway hyperresponsiveness and airway obstruction. Asthma 
prevalence has increased in the recent years, mainly in industrialized countries, possibly due to 
environmental and lifestyle changes, including diet (Malli et al. 2014). Airway inflammation associated 
with asthma may be partially triggered by aggravated oxidative stress and pro-inflammatory properties 
associated with western diet. 
Dietary habits 
Epidemiological research on the association between diet and asthma is fluent. Different components 
found in foods have antioxidant, anti-allergic and anti-inflammatory properties, which may protect 
against asthma development. The majority of epidemiological studies suggest that greater adherence to 
western dietary patterns (i.e. high consumption of alcohol, meat, dairy products and processed food) and 
reduced consumption of fruits, vegetables, whole grain cereals, and fish may result in greater asthma risk. 
Association of asthma with dietary habits has found support in various studies suggesting that higher 
intake of soft drinks, energy drinks, sugar added drinks (i.e. tonic, ice tea), and fast food and butter are 
associated with increased asthma risk. Experimental evidence suggest that dietary habits may enhance 
inflammatory responses and alter the Th1/Th2 balance, thus underlying the association with asthma 
(Zhang et al. 2016). 
The association of dietary patterns with asthma control and acute exacerbations of the disease are well 
studied and the results are straightforward; adherence to western diet has a negative impact on asthma 
control, while high fresh fruit and vegetables consumption and high fish consumption is associated with 
fewer exacerbations and better asthma control (Guilleminault et al. 2017; Laerum et al. 2007; Miyamoto 
et al. 2007). Importantly, current guidelines encourage patients with asthma to consume a diet high in 
fruit and vegetables. Similar results are obtained in children. High fruit intake, and especially apples, 
citrus fruit and tomatoes, are negatively associated with wheezing and asthma risk suggesting a possible 
role for flavonoids (Seyedrezazadeh et al. 2014). 
Vitamins 
Extensive data have examined the possible association of asthma risk and vitamins’ consumption based 
on the hypothesis that a decline in dietary antioxidants intake may increase asthma susceptibility. 
Experimental data support the aforementioned hypothesis; Vitamin A deficiency worsens ovalbumin-
induced lung inflammation through enhanced Th2 responses (Cui et al. 2016), while vitamin E reduces 
ROS production and improves antioxidant defense in animal asthma (Muti et al. 2016). In the same 
context, observational studies have shown reduced levels of antioxidants vitamins in asthmatics. Low 
vitamin A has been reported in severe asthma and may lead to increased airway hypersensitivity. 
Similarly, vitamins C and E have been inversely correlated with asthma risk. 
Interventional studies examining the effect of vitamin supplementation in asthmatics are inconclusive. 
While some studies have shown significant improvements in asthma symptoms or pulmonary function 
following vitamin E supplementation others have shown no important clinical benefit. Interestingly, 
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multiple nutrient supplementation including vitamin A, C, and E has proven beneficial in asthma patients. 
Overall the beneficial effect of dietary antioxidants has not been proven yet although the data point to that 
direction. 
Vitamin D is under examination as a probable modulator of the development of respiratory diseases 
characterized by chronic lung inflammation. Epidemiological studies have proven that vitamin D 
deficiency is common among asthmatics. Serum vitamin D is inversely correlated with airway 
hyperresponsiveness to metacholine and exercise-induced bronchoconstriction and vitamin D deficiency 
has been associated with airway remodeling and asthma severity. Vitamin D supplementation improves 
asthma symptoms while there seems to be no clinical evidence for the reduction of asthma exacerbation. 
However the relationship between vitamin D with pulmonary function and control of asthma is not 
consistent among studies. To summarize, the current data provide strong evidence for a beneficial effect 
of vitamin D in asthma but the clinical benefit of vitamin D supplementation is uncertain. 
Minerals 
Little is known concerning the association of minerals with asthma. Folate deficiency is associated with 
severe asthma exacerbations. Asthma patients present reduced selenium concentrations although selenium 
supplementation has no clinical benefit in asthmatics. 
Fatty Acids 
Epidemiologic studies have shown that populations with increased omega-6 polyunsaturated fatty acids 
(PUFAs) consumption have greater asthma predominance in contrast to those consuming increased 
omega-3 fatty acids. One possible explanation is that omega-3 fatty acids produce eicosanoids that are 
less pro-inflammatory (prostaglandin E3, leukotriene B5) than those derived from omega-6 fatty acids  
and because metabolites of omega-3 fatty acids have the capability to dissolve inflammation. A 20-years 
follow-up longitudinal study revealed that consumption of long-chain omega-3 PUFAs was significantly 
related to a low rate of incidents of asthma (Li et al. 2013), while high omega-3/omega-6 ratio has been 
associated with reduced airway hyperresponsiveness (as suggested by reduced metacholine-induced 
provocative dose) and leukotriene 4-excretion. However, the beneficial effects of PUFAs are not 
consistent among studies and a meta-analysis has suggested that omega-3 may reduce the risk asthma in 
children with no effects in adults. Although experimental data suggest a beneficial role of omega-3 in 
asthma, their benefits in real life remain to be clarified. In the same context, PUFAs supplementation 
studies have inconsistent results possibly due to methodological discrepancies. 
Probiotics-Prebiotics 
Probiotics such as lactobacilli and bifidobacteria may reduce asthmatic symptoms by enhancing T 
regulatory cells development and rebalancing Th1/Th2 responses toward a Th1-dominant state. 
Experimental evidence demonstrated that higher intake of the probiotic lactobacillus paracasei L9 
prevents particulate matter 2.5 (PM2.5)-induced enhancement lung inflammatory response (Wang et al. 
2017), whilst in a murine house dust mite-induced asthma model dietary prebiotics prevented and reduced 
symptoms of asthmatic disease (Verheijden et al. 2015). Two meta-analyses referred that probiotics may 
not be efficient at decreasing the risk of asthma and wheezing (Cabana et al. 2014; Forno et al. 2013). 
However, a double-blind controlled randomized study (RCT) showed synbiotic may decrease episodes of 
viral respiratory infection in asthmatic children (Ahanchian et al. 2016). Further research with long-term 
clinical trials needs to be conducted to assess the effectiveness of specific strains of probiotics and 
prebiotics in asthma. 
Phytochemicals 
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Phytochemicals are defined as bioactive non nutrient plant compounds in fruits, vegetables, grains, and 
other plant foods that have been linked to reducing the risk of major chronic diseases and have been 
studied mainly in animal models of asthma with encouraging results. For example, kaempferol is 
efficacious in improving epithelial thickening and airway smooth muscle hypertrophy (Shin et al.2015). 
Curcuma longa extract and its component curcumin has antioxidant and anti-inflammatory properties 
suggesting a therapeutic prospective. Propolis extracts containing flavonoids and phenolics exert anti-
inflammatory properties by free radical scavenging in mouse covalbumin-induced asthma model (El-Aidy 
et al. 2014). Similarly aerolised honey reduces airway inflammation. Ginger suspends lung inflammation 
by suppressing Th2-mediated immune responses and airway eosinophilia (Ahui et al. 2008). 
 
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)  
COPD is currently the fourth leading cause of death and a major cause of chronic morbidity. The disease 
is characterized by persistent respiratory symptoms and airway obstruction due to airway abnormalities 
usually caused by exposure to noxious particles or gases. The main risk factor is smoking and the disease 
results from a complex interaction between genetic and environmental factors. 
Nutritional support is indicated for malnourished patients since low BMI is associated with worse 
outcomes in COPD and poor diet contributes to skeletal muscle dysfunctions. Current guidelines suggest 
that all COPD patients should have general advice on healthy living including diet (GOLD 2017). For 
more information concerning nutritional support in COPD the reader is referred to published review 
(Collins et al. 2013). Here, we will address the possible effects of the most important nutrients or nutrient 
groups in COPD. 
Dietary habits 
Epidemiologic (both retrospective or not retrospective) studies have proven that dietary patterns with 
increased consumption of fruit, vegetables, fish, and whole grains are associated with decreased 
development of COPD in smokers and nonsmokers, better pulmonary function and decreased long-term 
COPD mortality, while a decrease in fresh fruit intake is associated with a greater fall in FEV1 (Carey et 
al. 1998). Mediterranean diet has been related to a 50% reduction in the risk of COPD (Varraso et al. 
2007). Alike, a randomised intervention study of COPD patients showed that an increase of fruit and 
vegetables consumption over a period of 3 years resulted in preseved  pulmonary function (Keranis et al. 
2010). 
Vitamins-Antioxidants 
The systemic inflammation related to COPD may be triggered by the impaired oxidative stress that is 
prevalent in the disease. The level of airway inflammation in COPD correlates with disease severity and 
is involved in disease pathogenesis. Thus, reduction of oxidative stress through diet may protect against 
the development of COPD. Epidemiological studies have almost unequivocally suggested that vitamin C 
is related to better lung function regardless of smoking history (for more details see the section on 
pulmonary function). Serum vitamin A is negatively related to the presence of COPD. Antioxidant 
supplementation of vitamins A, C and alpha-lipoic acid reduces oxidative stress in COPD. Low α-
tocopherol concentrations in lung tissue are related to more severe cases of COPD (Agler et al. 2013). 
However, few interventional studies exist. Vitamin E supplementation in almost 39.000 females 
demonstrated a reduction in the diagnosis of COPD (Agler et al. 2011), while others have challenged this 
finding (Heart Protection Study Collaborative Group 2002). Taken the above into account, it seems that 
the role of antioxidant supplementation in COPD is not fully explored. Exploration of their role should be 
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examined with caution due to the safety concerns associated with increased lung cancer prevalence 
(Albanes et al. 1996). 
Interestingly, vitamin D deficiency accelerated emphysema in animal models through increased 
protease/anti-protease ratio (Crane-Godreau et al. 2013). Vitamin D deficiency has been consistently 
reported in the COPD population and has been associated with recurrent exacerbations and 
hospitalization. Vitamin D supplementation has no effect on spirometry parameters or exacerbations 
frequency or time to first exacerbation except in patients with dramatically low vitamin D levels. 
However, vitamin D intake has been associated with improvement in inspiratory muscle strength and 
oxygen uptake (Hornikx et al. 2012). 
Phytochemical-plants 
A link has been suggested between phytochemicals and COPD. Delphinidin and cyaniding decrease the 
production of IL-8 in cells after cigarette smoke extract treatment (Flores et al. 2012). Lycopene, 
proanthocyanidin and quercetin reduces inflammatory mediators and oxidative stress indicators in THP-1 
macrophages exposed to cigarette smoke (Günay et al. 2016; Palozza et al. 2012). Green tea limits 
oxidative stress and protease/anti-protease imbalance in the airways after exposure to cigarette smoke 
(Chan et al. 2012). Spirulina consumption decreases oxidative markers and increases antioxidants in 
COPD patients (Ismail et al. 2014). Sulforaphane stimulates nuclear factor erythroid-2 related factor 2 
(Nrf2) activity in vitro and in vivo thereby possibly decreasing oxidative stress and ameliorating bacterial 
clearance in lung macrophages (Harvey et al. 2011).  
The literature on dietary intervention with plants as a treatment on COPD has also grown but the level of 
evidence is low and most of the studies are not encouraging. For example, pomegranate juice 
supplementation adds no benefit to the current standard therapy of patients with COPD. However, 
treatment with pingchuan guben decoction reduces symptoms, improves pulmonary function and reduces 
exacerbations of COPD and sulforaphane does not affect antioxidants levels or inflammatory markers in 
COPD. Clearly much are yet to be discovered concerning implication of phytochemicals in COPD. 
Minerals 
A number of experimental studies suggest a possible link of minerals with COPD, but the quality of 
evidence is low. Experimental studies demonstrate that copper deficiency results in emphysematous 
destruction of the lungs and an increase of the mean alveolar airspace areas and mean linear intercept 
(Mizuno et al. 2012). Mg deficient patients with COPD report notable worse COPD-related Quality of life 
although Mg levels are not associated with spirometry values. Beetroot juice, which is rich in nitrate 
(NO3
-
) reduces oxygen consumption during exercise in COPD patients. COPD patients present lower 
calcium, phosphorus and iron intake while an inverse association exists between dietary calcium intake 
and COPD risk. 
Fatty acids 
PUFAs intake may protect against COPD development through reduction in COPD related inflammation. 
Varraso et al. (2015) reported no significant relationship between PUFAs consumption and risk of COPD 
in two cohort studies. However, high dietary intake of omega-3 is inversely associated with COPD risk in 
a dose-dependent manner. The associations between PUFAs and COPD are inconsistent. PUFAs 
supplementation improves exercise capacity in COPD  and may reduce the rate of lung function 
deterioration. Based on limited proof there is a weak support for the role of omega-3 PUFAs in COPD 
with some evidence for the improvement of functional ability. 
Probiotics-fibre 
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Probiotics may act as immunomodulatory agents and may regulate immune responses responsible for 
COPD. The aforementioned hypothesis has little literature confirmation. Mortaz et al. (2013) suggested 
that probiotic Lactobacillus casei strains shirota (LcS) may be useful in COPD patients, especially those 
with recurrent viral infections, since daily consumption of LcS increases natural killer cell activity in 
smokers and thus  may be implicated in COPD exacerbations (Morimoto et al. 2005; Naruszewicz et al. 
2002). Increase in dietary fibre consumption has been associated with reduced COPD risk, improvement 
in pulmonary function and decreased respiratory symptoms. 
 
LOWER RESPIRATORY TRACT INFECTIONS (LRTIs)  
Lower respiratory infections (LRTIs) are a leading cause of morbidity and mortality affecting both adults 
and children worldwide. Although not uniformly defined, the term LRTIs usually refers to infections of 
the airway such as acute bronchitis and acute bronchiolitis, as well as infection of the lung alveoli 
(pneumonia). Community acquired pneumonia (CAP) is one of the most common infectious diseases 
worldwide and is defined as pneumonia in patients that do not reside in a long-term care facility or 
pneumonia that occurs within 48 hours after hospital admission. Pneumonia that was not incubating at the 
time of hospital admission and that occurs more than 2 days after hospitalization is termed hospital-
acquired pneumonia. Health-care associated pneumonia mainly affects patients that were hospitalized for 
more than 2 days in the last 90 days or residents of long-term care facilities. 
The increase in the incidence of acute lower respiratory infections (mainly pneumonia), as well as their 
severity and mortality, may be associated with malnutrition, and impaired immune response may be one 
of the underlying mechanisms. Several nutrients have immunomodulatory roles and studies have 
suggested that they may be implicated in the development as well as the outcome of LRTIs. 
Vitamins-Antioxidants 
Several vitamins may be involved in the development and outcome of respiratory infections. Nutrients 
with antioxidant properties may enhance immune response and natural defenses and therefore one may 
speculate that they may protect against LRTIs. However, data in the literature are not straightforward 
concerning this hypothesis. Besides their antioxidant capacity, vitamins may exert direct roles in the 
immune system. For example, vitamin C enhances the function of phagocytes and the proliferation of 
lymphocytes. In a population based study vitamin C relieved oxidative stress and proinflammatory 
mediators associated with pneumonia (Chen et al. 2014). 
Vitamins A and C deficiency may be related to a higher burden of respiratory infections, possibly 
thorough the negative impact on immune function. However, others have failed to demonstrate an 
association of vitamins C and E and beta carotene with milder forms of respiratory infections, such as 
common cold (Hemila et al. 2002; Takkouche et al. 2002). On the contrary, low levels of vitamins A and 
D are related to severe outcomes of LRTIs such as admission to ICU or need of mechanical ventilation. 
Interestingly, in a Cochrane meta-analysis, vitamin A did not confer a significant benefit in preventing 
LRTIs (Chen et al. 2008). In the same context, studies have examined the possible benefit of antioxidant 
vitamins supplementation in LRTIs with conflicting results. Vitamin A supplementation does not affect 
the clinical course or reduce severity of CAP. On the contrary, vitamin C intake reduces the duration of 
mechanical ventilation in patients with pneumonia and decreases the pneumonia risk in patients with 
vitamin C shortage. A study showed reduced hospitalization duration for pneumonia in patients with 
vitamin C supplementation (Yaqub et al. 2015).  
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Vitamin E intake may reduce the incidence of pneumonia in elderly. However, vitamin E and β-carotene 
addition does not affect the risk of severe hospital-treated pneumonia, eventhough some have stated that 
vitamin E might augment the risk of pneumonia in patients with increased vitamin C intake. Interestingly, 
dietary supplementation which contained vitamins (A, B1, B2, B3, B5, B6, B7, B12, C, E), and minerals 
(selenium, zinc, copper, manganese) decreases the incidence of clinically diagnosed acute respiratory 
infections, which include common cold, flu, pharyngitis, sinusitis, laryngitis, bronchitis and pneumonia 
(Bernal-Orozco et al. 2015). The conflicting results may be due to the heterogeneity of studies population 
since some have speculated that the beneficial effects of vitamin supplementation depend on the 
prevalence of vitamins deficiency in the patients. 
Vitamin D has attracted a lot of attention recently since it possesses significant immunomodulatory 
properties. Vitamin D suppresses T-helper cell (Th-1) and enhances Th-2 immune responses and induces 
the production of antimicrobial peptides such as cathelicidin. Observational studies have linked vitamin D 
deficiency with increased risk of LRTIs in both adults and children. Vitamin D deficiency has been 
associated with both increased risk and severity of LRTIs in children. Similar results have been obtained 
in adults where vitamin D deficiency has been inversely associated with CAP severity. The role of 
vitamin D supplementation in LRTIs prevention and treatment has been studied as well. Data from RCT 
suggest that vitamin D may have a protective role against influenza infection (Urashima et al 2010), 
although not associated with the duration of the resolution of pneumonia or the incidence of LRTIs 
(Robertsen et al. 2013). Interestingly, a recently published meta-analysis suggested that vitamin D 
supplementation may prevent LRTIs (Martineau et al. 2017). Although data suggest that vitamin D has 
important implications in LRTIs, the beneficial effect of vitamin D supplementation remains unclear. 
Probiotics-Prebiotics 
Data support the use of probiotics for the prevention and treatment of gastroenteritis. The possible role of 
probiotics and prebiotics in respiratory infections has attracted attention as well. For example, probiotics 
like lactic acid bacteria have proven effects in innate and humoral immune response against streptococcus 
pneumoniae associated LRTIs. Meta-analyses support that the use of probiotics is related to a statistically 
notable decrease in the prevalence of hospital induced pneumonia (Liu et al. 2012). Similarly, 
consumption of probiotics is associated with lower occurrence of VAP. Probiotic introduction in the diet 
reduces cases of LRTIs as well as RTIs in the elderly. Bernard et al. (2015) demonstrated that prebiotics, 
such as pectin-derived acidic oligosaccharides taken out from citrus, improved the outcomes of 
pseudomonas aeruginosa lung infection in mice by regulating the intestinal microbiota and the 
inflammatory and immune responses. As there was a decrease in bacterial load, pectin-derived acidic 
oligosaccharides could be suggested as an adjuvant therapy to antibiotics. A systematic review and 
network meta-analysis demonstrated that synbiotic therapy (combination of probiotics and prebiotics) was 
the best regulated course in decreasing pneumonia in adult surgical patients in comparison with probiotics 
and prebiotics alone (Kasatpibal et al. 2017). Although the aforementioned data are encouraging, further 
studies are warranted, before any definite suggestions are made concerning probiotics and prebiotics role 
in LRTIs. 
Fatty Acids 
PUFAs have great immunomodulatory and inflammatory effects. Experimental evidence suggest that 
PUFAs promote phagocytosis of pseudomonas aeruginosa (Adolph et al. 2012) as well as the survival of 
mice following infections of pseudomonas aeruginosa and klebsiella pneumoniae (Caron et al. 2015). 
Similarly, omega-3 PUFAs amplifies phagocytic ability of mice alveolar macrophages and reduces 
alveolar macrophage apoptosis by streptococcus pneumoniae (Saini et al. 2013). High consumption of 
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ALA and linoleic acid is related to reduced pneumonia risk. On the contrary, DHA and EPA have been 
associated with increased CAP risk while oleic acid is inversely associated with pneumonia prevalence. 
Dietary supplementation with DHA and arachidonic acid decreases viral infections and therefore LRTIs. 
Omega 3 intake is beneficial in ARDS patients. However a meta-analysis suggests that there are no 
benefits at omega 3 supplementation in patients with ARDS (Li et al. 2015). The data concerning the role 
of PUFAs in RTIs are inconsistent. 
Phytochemicals 
Current data suggest that phytochemicals may have preventive and therapeutic role in RTIs however the 
quality of evidence is low. Green tea consumption is related to a lower risk of death from pneumonia. 
Pleuran decreases the number of pneumonia and bronchitis in children. Manuka honey has antimicrobial 
activities against pseudomonas aeruginosa. Extract from North American ginseng (panax quinquefolius) 
suspends pseudomonas aeruginosa development. Interestingly, combination therapy of curcumin with 
antibiotics in mice models reduces inflammation, and bacterial proliferation and lung tissue injury. 
Minerals 
Data suggest clinical benefit for mineral supplements like zinc in LRTIs. A meta-analysis concluded that 
zinc supplementation for more of 3 months decreases the risk of LRIs (Roth et al. 2010). Zinc 
supplementation may reduce pneumonia mortality in children and may serve as an adjuvant therapy (Shah 
et al. 2017). Zinc reduces the incidence of severe pneumonia. In the same context, selenium reduces VAP 
prevalence. Selenium, zinc and copper administration is linked to reduced incidence of nosocomial 
pneumonia. 
 
TUBERCULOSIS (TB) 
Tuberculosis (TB) represents an infectious disease usually caused by Mycobacterium tuberculosis (Mtb). 
One third of the world population is infected with Mtb, while TB was responsible for 1.3 million deaths 
in 2016. About 90% of patients do not present symptoms and suffer from latent TB, while active cases 
present with cough, hemoptysis, fever, night sweats and weight loss. TB can affect any part of the body 
although most commonly affects the lungs. The disease pathogenesis commonly involves the formation 
of caseous granulomas in infiltrated tissues involving macrophages, T-lymphocytes, B-lymphocytes and 
fibroblasts. Treatment of TB involves the combination of antituberculosis drugs for long periods of time.   
Dietary patterns 
Several factors make people more susceptible to TB. Malnutrition among others has long been recognized 
as a risk factor for pulmonary TB. Data on the role of dietary patterns in TB are sparse. Poor fruit and 
vegetable intake is related to an increased susceptibility to infection with Mtb but not active TB. In an 
animal experiment it was found out that alcohol consumption dulled the development of the adaptive 
immune response to BCG vaccination (Porretta et al. 2012).  
Vitamins-antioxidants 
Although studies have shown deficiency of several antioxidant vitamins in TB, the available data cannot 
confirm causality. Experimental data suggest that vitamins like vitamin C and E have bactericidal activity 
against Mtb and thus may exert potential benefits to anti-tuberculosis treatment. TB patients present low 
levels of vitamin A, considering it as a risk factor of TB infection and clinical severity. Similar results 
have been reported for vitamins E, A and C. Taken the above into consideration, nutritional supplements 
could help people recover from TB due to their effects on the immune system. However, there are no 
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clear data that routine supplemention provides clinically important benefits. Although vitamins and 
micronutrients supplementation may help the treatment of these patients in terms of earlier sputum smear 
conversion or reduced hepatotoxicity, no definite conclusions can be drawn yet. 
The strong association of vitamin D deficiency and TB may be due to the production of cathelicidin 
which is implicated in the innate immune response to Mtb infection (Liu et al. 2006). Observational 
studies have shown a positive association between low levels of vitamin D and TB prevalence. 
Additionally, vitamin D hypovitaminosis is a risk factor for worse treatment outcomes like delayed 
sputum conversion.Vitamin D deficiency has been widely accepted as a risk factor for active TB. 
However, the effect of vitamin D supplementation in TB remains controversial. Adjunct therapy with 
vitamin D has some beneficial effects towards clinical recovery. However, the results are inconsistent 
among the studies. At this point the beneficial effect of vitamin D supplementation remains unclear and 
high-quality studies are necessary to establish the role of vitamin D manipulation in TB. 
Minerals 
Patients with TB present low serum concentrations of zinc and selenium, high levels of copper  and 
cobalt. Low plasma selenium levels is a risk factor related to anemia in these patients (Van Lettow et al. 
2005). High copper is related to worse outcomes and low zinc is associated with clinical severity. 
Experimental evidence suggest that copper is essential for the control of Mtb infection (Wolschendorf et 
al. 2011). Further studies in this field are clearly needed.  
Fatty acids 
The impact of PUFAs on TB is not well known. Omega-3 PUFAs supplementation might have a harmful 
effect on immunity against Mtb. Experimental data have linked omega-3 PUFAs with reduced skin test 
positivity and reduced inflammatory response to Mtb. Although observational data suggest that omega-3 
and omega-6 consumption may be related to reduced risk of active TB, overall the available data suggest 
that PUFAs may increase susceptibility to Mtb infection. Clearly well-designed studies are warranted in 
order to elucidate PUFAs role in TB in vivo. 
Phytochemicals-plants 
Many studies have been conducted on the potential effect of medicinal plants as alternatives and 
adjunctives therapies for the treatment of TB. It has been reported that ursolic acid and hydroquinone may 
have chemotherapeutic potency against Mtb and immunoregulatory properties against TB in mice. 
Curcuma longa provides defense against Mtb infection in alveolar macrophages, via repression of nuclear 
factor-kappa B (NFκB) activation (Bai et al. 2016). In addition, aristolochia brevipes, garlic and garlic 
derived fatty acids, and ambrosia confertiflora have antibacterial activity against Mtb. Excoecaria 
agollacha may protect against multi-drug resistant TB (Amudha et al. 2014). Pomegranate fruit inhibits 
Mtb and manuka honey may be efficient as a hepatoprotective agent. Although the aforementioned data 
are encouraging, the lack of well-designed clinical trials limits their importance. 
Probiotics 
Strains of lactic acid bacteria, as l. rhammosus GG and bifidobacterium bifidum MF 20/5  increase the 
autophagic capacity of mononuclear phagocytes in response to Mtb antigen in a vivo study (Ghadimi et 
al. 2010). Unfortunately, there are no studies about the impact of probiotics on TB. 
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LUNG CANCER  
Lung cancer (LC) is the leading cause of cancer death in the United States. The vast majority of cases are 
caused by smoking with the remaining often due to a combination of genetic factors and exposure to 
radon or asbestos. Most patients are not curable, thus avoidance of risk factors, mainly smoking, is of 
special importance in order to prevent the disease. An issue of ongoing research is the effect of diet on 
lung cancer development and its therapeutic potential. 
Dietary patterns 
Emerging data have indicated that dietary habits play a crucial role in lung cancer development and as a 
result they have attracted increased attention. Processed meat and meat mutagen (found in fried, 
barbecued, and processed meat), red meat, white bread, fat and high dietary glycaemic index foods, 
polycyclic aromatic hydrocarbons (found in charcoal-broiled, fried, and smoked meat) and coffee 
consumption have all been associated with increased lung cancer risk mainly among smokers. On the 
contrary, fish consumption, fruits and vegetables and a healthy dietary pattern have been consistently 
associated with lower lung cancer risk. Of great importance seems to be the adherence to the 
mediterranean diet that has strong evidence in favor of a reduced lung cancer risk. 
Vitamins-Antioxidants 
Oxidative stress has been implicated in lung cancer development and thus one may speculate that dietary 
antioxidants may prevent carcinogenesis. Several epidemiological studies have associated antioxidant 
intake with lower lung cancer risk. Intake of vitamins A, C, and E may provide protection against lung 
cancer development but with a possible modification of this effect by smoking habit. Similar data have 
been reported for riboflavin (B2) and folate (vitamin B9). However, interventional studies have not 
replicated these results, while the use of antioxidants supplements may be harmful. In a double blind RCT 
which involved almost 30.000 male smokers, there was an association of beta-carotene supplementation 
with higher incidence of LC as early as 18 months after the initation of the study (Albanes et al. 1996). 
Similarly, a study involving 18.000 men and women at high risk for LC supplemented with beta carotene 
and vitamin A was stopped early due to higher death rate in the antioxidant groups (Omenn et al. 1996). 
On the contrary, they seem to be harmful. Surely, the available data do not provide any evidence of any 
preventive effect. The mechanism underlying the potential increase in lung cancer incidence is not known 
but studies have suggested that antioxidants may promote tumor growth and metastasis. 
The effect of antioxidant supplements during lung cancer treatment is not well studied. Some have shown 
that vitamin addition combined with chemo therapy may inhibit cell proliferation in cell lines (Lee et al. 
2017). However, studies have shown inconsistent results and some have reported worse outcomes. 
Therefore, antioxidant supplements should be used with caution by lung cancer patients. 
Vitamin D may exhibit anti-carcinogenic effects via the inhibition of cell proliferation and angiogenesis, 
as well as the enhancement of apoptosis and cell differentiation. Experiments have shown that vitamin D 
intake might provide protection against lung cancer development and metastatic ability via giving off of 
E-cadherin and catenin, which help the adherence of cancer cells and decrease the possibility of 
metastasis (Zhou et al. 2005). In the same context, high levels of 25-hydroxyvitamin D [25(OH)D] may 
be related to a decreased risk of LC, particularly in people with vitamin D deficiency. Some have reported 
that the protective nature of vitamin D against LC is limited to women and non-smokers. Data have 
connected positively vitamin D with LC mortality. Unfortunately, literature lacks data from well-designed 
studies and the causal direction of these results cannot be established. 
 
Institutional Repository - Library & Information Centre - University of Thessaly
05/02/2019 21:24:25 EET - 137.108.70.13
16 
 
Minerals 
Dietary mineral intake may influence lung cancer development but the direction of the association 
depends on the type of the mineral. A prospective cohort study among 482.875 participants suggested that 
total calcium consumption was protective for smokers and individuals with adenocarcinoma, while total 
magnesium intake increased risk in men and smokers and total iron consumption was inversely related to 
risk in women. Mineral intake from supplements did not influence LC risk (Mahabir et al. 2010). A diet 
rich in zinc and iron may be related to reduced risk but no relationship was found between selenium, 
calcium, magnesium and copper consumption (Muka et al. 2017). Others have associated low selenium 
with high risk of LC (Jaworska et al. 2013), while selenium supplementation is not benefit in terms of 
prevention of second primary tumors in patients with resected NSCLC. 
Fatty acids 
Fatty acids, especially omega-3 PUFAs, have been associated with a lower predominance of various types 
of cancer. Experimental studies support the protective role of PUFAs in LC possibly through increased 
oxidative stress and apoptosis of cancer cells and modulation of cyclooxygenase activity and cell surface 
receptors (Kim et al. 2015).The aforementioned data are consistent with observational data suggesting 
that high fish consumption, which is rich in n-3 PUFAs is related to a reduction of LC risk even after 
adjustment for smoking status. Supplementation of eicosapentaenoic acid (EPA) increased lean body 
mass, energy and protein intake and reduced fatigue and neuropathy in non-small cell lung cancer 
(NSCLC) patients undergoing chemotherapy (Sánchez-Lara et al. 2014). Adjunctive omega-3 
supplementation in LC therapy may prevent cachexia, and improve performance status and physical 
activity in LC patients (Finocchiaro et al. 2012). Due to the limited available data that are generally based 
on small cohorts, no definitive conclusions can be drawn. 
Phytochemicals-plants 
Many phytochemicals have been studied in the context of LC due to their possible role in LC cells 
apoptosis, chromatin remodeling, and DNA methylation among other pathways. Quercetin-rich food is 
inversely associated with LC risk, whilst quercetin enhances the activity of anti-cancer drugs. (6)-shogaol 
suppresses the growth of NSCLC cells and enhances apoptosis in cancer cells. Silibinin in combination 
with epigenetic drugs (HDAC or DNMT inhibitor) inhibits both aggression and migration of NSCLC 
cells and could be a potent treatment to more advanced stages of NSCLC, whilst combination of indole-3-
carbinol and silibinin intake may protect against LC. Both green and black tea consumption are related to 
lower risk for LC. Triptolide which has been studied for its anti-rheumatic effects, shows anticancer 
properties against NSCLC. Chlorella sorokiniana causes mitochondrial-mediated apoptosis in NSCLC 
cells, whilst chlorella vulgaris inhibits LC cells growth and migration. 
Many studies have assessed the inhibitory activity of curcumin on lung cancer cell line growth and 
metastasis in vitro and in vivo as well as its reinforcement of anti-cancer drugs. Α few studies proved the 
inhibitory effect of panax ginseng on tumor growth and lung metastasis in vitro and in animals. 
Unfortunately, RCTs are lacking and the aforementioned findings are mostly based on experimental 
studies. 
 
CYSTIC FIBROSIS  
Cystic fibrosis (CF) is a genetic disorder caused by mutations of the gene for the cystic fibrosis 
transmembrane conductance regulator (CFTR) protein. CFTR is involved in sweat, digestive fluid and 
mucus production and when affected it results in thicker secretions. The disease affects the lungs due to 
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mucus clogging of the airways resulting in inflammation and infection. The thick mucus blocks the 
digestive system causing meconium ileus and in later life the thickened secretions of the pancreas blocks 
the exocrine part of the organ and result in irreversible damage. Due to malabsorption, patients with CF 
are often malnourished and have poor growth. Replacement of digestive enzymes is indicated in CF, 
while they present malabsorption of fat-soluble vitamins (A, D, E, and K). Also, they exhibit signs of 
oxidative stress, due to the inflammation and malabsorption of vitamins A and E. CF patients should 
consume 120% to 150% of the recommended daily allowance (RDA) for energy expenditure, with 40% 
coming from fat. Nutritional supplementation may include omega-3 PUFAs, vitamins A, D, E, K, 
proteins ≥120% of RDA. 
Concerning the lung, in the early stages, inflammation and decreased mucociliary clearance results in 
copious phlegm production and insufficient coughing. In later life patients develop structural changes in 
the lungs, mainly bronchiectasis. For malnutrition in CF the reader is refer to a published review paper 
(Culhane et al. 2013). Here we will report the main findings on the role of dietary compounds in the 
disease. 
Vitamins-Antioxidants 
Vitamin C reduces with age in people with CF and supplementation with antioxidant vitamins may retard 
the deterioration of pulmonary function. Experimental data suggest that vitamin C activates the CFTR 
channel in the respiratory tract (Fischer et al. 2004). Clinical studies suggest that vitamin C concentration 
in CF patients is associated with indexes of lung inflammation. High levels of vitamin A are related to 
improved lung function in CF patients and β-carotene supplementation could benefit CF patients. Vitamin 
E levels have been reported low in CF. Little is known about vitamin A. High α-tocopherol levels have no 
beneficial effects on pulmonary function in CF patients. RCTs in the field are lacking. 
Vitamin D supplementation has anti-microbial and anti-inflammatory properties in CF patients and is 
related to reduction in inflammatory cytokines, i.e. IL-6 and TNF-a (Grossmann et al. 2012; Herscovitch 
et al. 2014). Vitamin D deficiency is associated with pulmonary exacerbations. Similarly, vitamin D 
consumption may regulate positively inflammation in CF by decreasing serum total IgG levels, serum 
haptoglobin and erythrocyte sedimentation rate (Pincikova et al. 2011). 
Minerals 
Serum levels of calcium, copper, and iron in CF patients are reduced during exacerbations of the disease. 
Zinc deficiency is common in CF patients and low zinc levels are associated with worse pulmonary 
function. However, zinc supplementation does not improve pulmonary function neither decreases 
pulmonary infections (Sharma et al. 2016). CF patients have lower levels of selenium. Iron deficiency is 
usual in adults with CF and associated with disease severity. Iron administration does not reduce 
respiratory symptoms or change the sputum microbiome in CF patients (Gifford et al. 2014). CF patients 
have increased lung iron levels that enhance ROS production and encourage bacterial growth (Childers et 
al. 2007). High iron levels in the airways of CF patients may conduce to the sensibility to chronic 
bacterial infections that are related to CF. Administration of iron chelators might isolate host iron and 
prevent approachability of iron to bacteria (Aali et al. 2017). 
Fatty Acids 
Low-dose supplementation with omega-3 and omega-6 PUFAs improves lung function, respiratory 
exacerbations, antibiotic consumption, lean body mass, inflammation, and oxidative markers. A RCT also 
showed that omega-3 PUFAs may decrease leukotriene LTB4/LTB5 ratio, demonstrating anti-
inflammatory effects (Panchaud et al. 2006). 
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Phytochemicals 
Curcumin may stimulate CFTR Cl
-
 channels (Berger et al. 2005). Garlic improves lung function in CF 
patients having chronic Pseudomonas aeruginosa infection. Rhodiola kirilowii (Regel) maxim and cocoa 
flavanols have antidiarrheal activity in CF patients by inhibition of CFTR Cl
-
 channel activity (Schuier et 
al. 2005). Also, bergamot (citrus bergamia risso) extracts inhibits IL-8 expression in an in vitro study 
(Borgatti et al. 2011).  
Probiotics 
A systematic review revealed that the effectiveness of probiotics in children with CF is restricted 
(Ananthan et al. 2016). 
 
INTERSTITIAL LUNG DISEASES  
Interstitial lung diseases (ILDs) are  a group of heterogenous diseases of the lung that affect the 
interstitium. The group includes many different conditions. Here we will emphasize on two of the most 
common ILDs, Idiopathic Pulmonary Fibrosis (IPF) and sarcoidosis.  
The reduced antioxidant defense, causing oxidative stress and inflammation are two key triggers in the 
pathophysiology of IPF. A diet rich in antioxidants might have an advantageous effect on ILD patients 
and some argue that it might prevent against the development of IPF. In addition, fruit consumption may 
prevent the development of IPF. A study found a reduction in the risk of IPF, which is related to high 
consumption of green tea, vegetables, and higher intake of fish (Iwai et al. 1994). High consumption of 
vitamin A has been related to decreased rate of progression in asbestos-related lung fibrosis (Chuwers et 
al. 1997). However, the role of antioxidants is probably of limited importance since the administration of 
NAC in IPF patients offers no significant benefits (Idiopathic Pulmonary Fibrosis Clinical Research 
Network 2014). 
Vitamin D deficiency is konown in patients with ILD. Sarcoidosis patients should be supplemented with 
vitamin D, only when diagnosed with vitamin D deficiency due to the high levels of 1-a-hydroxylase in 
sarcoid granulomas. 
Several studies in animals have suggested  the potential therapeutic properties of phytochemicals in ILDs. 
Fenugreek (trigonella foenum graceum) seed extract and berberine exhibits anti-fibrotic results through 
induction of Nrf2 (an antioxidant balance regulation factor) and inhibits profibrogenic molecules in 
bleomycin-induced rat models (Chitra et al. 2015).  Citrus reticulata (commonly known as mandarin 
orange) extract inhibits the proliferation of human lung fibroblasts and inflammation (Zhou et al. 2013). 
Flaxseed oil, which is rich in omega-3 and omega-6 PUFAs, attenuates bleomycin-induced pulmonary 
fibrosis in rats and reduces pulmonary oxidative stress (Abidi et al. 2016). Intraperitoneal curcumin 
administration exhibited antifibrotic effects on bleomycin-induced pulmonary fibrosis in mice and 
curcumin administration prevents against the development of carbon tetrachloride-induced pulmonary 
fibrosis. Hesperidin reduces the severity of pulmonary fibrosis in rats. Nigella sativa has anti-
inflammatory and antifibrotic effects on bleomycin-induced pulmonary fibrosis in rats. Administration of 
quercetin could benefit IPF patients by reducing inflammation, oxidative stress, and retarding disease 
progression (Veith et al. 2017). Similarly, Boots et al. (2009; 2011) indicated that quercetin might be 
useful for sarcoidosis patients by decreasing OS and inflammation. 
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MATERNAL DIET AND DIET IN EARLY LIFE IN LUNG HEALTH 
Maternal diet in pregnancy is considered to be one of the most relevant prenatal and early postnatal risk 
factors for the development of respiratory diseases. The development of the lungs is almost completed 
prenatally and, following birth, airway development is mostly restricted to size growth. Thus, fetal or 
early life exposure may have disproportional effects on the development of respiratory diseases. Research 
has focused on the obstructive lung diseases such as asthma and COPD. 
Dietary patterns 
Various dietary patterns may contribute to lung development or disease. Experiments in animals showed 
that maternal high-fat diet and hypercaloric diet were associated with deteriorated fetal lung development, 
airway hyperresponsiveness and chronic airway inflammation in the offspring (Griffiths et al. 2016). 
In humans, high consumption of (processed) meat, fast food (i.e. large portions of processed meat, refined 
carbohydrates, saturated and trans-fatty acids, sodium, sugar, preservatives and colorants), are all 
associated with wheeze and asthma symptom in children. On the contrary, high maternal intake of peanut, 
milk, wheat, leafy vegetables, malaceous fruits and chocolate may be related to a decreased likelihood of 
wheeze and/or asthma but not consistently. Adherence to the mediterranean diet during pregnancy seems 
to be preventive for wheeze. Subsequently, early import of solid food has been associated with reduced 
probability of developing asthma. The effect of breastfeeding for 4-6 months or longer is related to 
reduced risk of developing asthma and LRTIs (Tromp et al. 2017).  
Vitamins-Minerals-Antioxidants 
Maternal dietary antioxidant intake may contribute to increases in asthma risk. Low maternal vitamin E 
and zinc intake is associated with increased asthma-like symptoms, whilst vitamin E levels during 
pregnancy are positively related to post-bronchodilator FEV1 (Devereux et al. 2006). Vitamin E affects 
positively neonatal airways epithelial cell secretory function (Miller et al. 2015). Increased intake of 
vitamin C in pregnancy is associated with wheezing. Interestingly, maternal antioxidant intake may 
decrease the risk of RTIs in the offspring. High maternal selenium and copper levels may prevent wheeze, 
an effect that is limited to the first years of life (Baiz et al. 2017). The current data support the association 
of antioxidants with childhood asthma but must be interpreted with caution, since the observational nature 
of the studies cannot establish causality. 
The data concerning vitamin D are rather conflicting. Experimental evidence suggest that prenatal 
vitamin D is associated with lung development and surfactant synthesis. Low maternal and low neonatal 
vitamin D levels have been linked to bronchopulmonary dysplasia, asthma and wheeze. Others have 
challenged these results reporting no relation of maternal levels of vitamin D with asthma and wheeze 
(Magnus et al. 2013). Low levels of vitamin D in newborns and low vitamin D blood levels have been 
linked to increased risk of LRTIs and higher airway resistance. 
Fatty Acids 
PUFAs intake in pregnancy seem to play a role in respiratory symptoms in the offspring. Increased 
consumption of omega-3 PUFAs in the maternal diet has protective effects against allergic diseases 
(eczema, rhino-conjunctivitis, asthma) in the offspring. In the same context, fish oil supplementation 
during pregnancy may prevent asthma, although the relationship may be limited to asthmatics mothers 
(Salam et al. 2005).  
Supplementation with omega-3 PUFAs in infants may influence later respiratory health. Infants who 
consumed omega-3 PUFAs had reduced odds of wheezing at 18 months, a result that is dulled at 3 and 5 
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years of age (Marks et al. 2006). Also, early introduction of fish into the diet (at <9 months of age) 
reduces odds of wheezing (Goksor et al. 2011) and is associated with a reduced risk of all asthma types. 
In addition, margarines consumption from mothers during lactation was weakly related to an increased 
risk of asthma (Lumia et al. 2012). 
Probiotics 
Despite evidence for an effect on immune development, overall the current data do not support an 
association of probiotic supplementation and childhood asthma. Evidence from two meta-analyses 
supported that prenatal and/or early life probiotic administration could not protect against asthma or 
childhood wheeze (Azad et al. 2013; Elazab et al. 2013). More studies are needed to assess the possible 
mechanisms through which probiotics could prevent respiratory symptoms in the offspring since most of 
the clinical trials currently available commence supplementation in late pregnancy. 
 
DIET AND PULMONARY FUNCTION 
A healthy overall diet, as assessed by the Healthy Eating Index 2005 (HEI-2005) is associated with better 
lung function as determined by the ratio FEV1/FVC and  FEV1%pred. Animal protein and PUFAs 
consumption show a positive association with pulmonary function, whereas there is a negative association 
between pulmonary function and total calories and dietary saturated fatty acids. A dietary pattern based 
on higher-antioxidant food consumption may be associated with improvement in lung function at least in 
COPD patients (Keranis et al. 2010). 
Epidemiological studies have indicated that vitamin C consumption is beneficially related to lung 
function, regardless of smoking intensity and prevents the development of emphysema in chronic 
smokers. Vitamin A is necessary for lung development and pulmonary cell differentiation and its 
deficiency could lead to lung dysfunction due to disordered composition of collagen IV and laminin and 
reduction on matrix metalloproteinase concentrations (Esteban-Pretel et al. 2013). B-carotene is positively 
associated with FEV1 and is related to slower decline of FEV1 in an 8-year follow-up study (Grievink et 
al. 2000). In accordance to these findings, serum carotenoids concentrations are inversely associated with 
a decline in lung function (Thyagarajan et al. 2011). 
High vitamin E intake has a positive association with FEV1 and FVC with a dose-dependent response, 
whilst others have questioned the relationship between vitamin E and lung function. An increase in serum 
selenium was associated with an increase in FEV1 among smokers (Hu et al. 2000). 
According to a nutritional epidemiological study, dietary intake of magnesium, folate (vitamin B9), niacin 
(vitamin B3), vitamins A and D, long chain unsaturated fatty acids (eicosenoic fatty acid and omega-3 
PUFAs), and dietary fiber are associated with better FEV1 in chronic smokers (Leng et al. 2017). It has 
been also suggested that keeping sufficient vitamin D levels is necessary for optimal lung health and may 
regulate the lung microbiome in a sex-specific fashion (Roggenbuck et al. 2016). Low ﬁbre intake is 
related to decreased measures of lung function. 
Anthocyanins (flavonoids found in fruits, mainly in berries) intake is associated with slower age-related 
rates of FEV1 and FVC decline (Mehta et al. 2016). 
 
Challenges in diet and lung health research 
Accumulated evidence from observational studies suggest that diet is a potential cofactor in lung health 
and disease. However, due to the nature of these studies (i.e. lack of control for biases that may influence 
Institutional Repository - Library & Information Centre - University of Thessaly
05/02/2019 21:24:25 EET - 137.108.70.13
21 
 
outcomes, often retrospective nature), the temporal relation cannot be stablished. Clearly, well designed 
studies (i.e. RCTs) are needed in order to determine causality and often the clinical importance of dietary 
interventions. The association of various nutrients with lung diseases needs to be addressed more 
thoroughly, like the potential implication of probiotics and phytochemicals with COPD or the role of 
minerals in asthma. 
Another important concern that needs to be studied is the potential effect of organic foods in lung health. 
Currently, products of organic farming are thought to be safer and more nutrient than conventional food, 
however there are no data examining the relationship with lung health.  
Additionally, the data are limited regarding the possible association of the cooking method applied to the 
foods with the development of lung diseases. For example, processed meat is high in nitrites (thus may 
contribute to lung inflammation) and benzo(a)pyrene which is mutagenic. Further high quality 
investigations are needed in order to clarify the possible link. 
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Table 1: Nutrients, diet and lung disease.  Beneficial effect; Negative effect;  No effect 
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Table 2:  The role of various nutrients and diet in asthma 
                       ASTHMA 
 MAIN FINDINGS COMMENTS 
Vitamin A Reduced levels in asthmatics, improve asthma symptoms Interventional studies are inconclusive 
Vitamin C Reduced levels in asthmatics, improve asthma symptoms Interventional studies are inconclusive 
Vitamin D 
Reduced levels in asthmatics, improves asthma symptom, is 
not related to asthma exacerbation 
Clinical benefit of vitamin D supplementation is uncertain 
Vitamin E Reduced levels in asthmatics, improve asthma symptoms Interventional studies are inconclusive 
Vit B9 (Folate) Deficiency is associated with severe asthma exacerbations Limited data available 
Selenium 
Reduced concentrations among patients, supplementation 
has no clinical benefit 
Limited data available 
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Omega-3 PUFAs Consumption may reduce the asthma risk Beneficial effects of PUFAs are not consistent 
Omega-6 PUFAs Consumption is associated with increased asthma risk Limited data available 
Probiotics May reduce asthmatic symptoms 
Mainly  experimental data available, limited data from clinical 
trials 
Western dietary patterns 
Adherence to western dietary patterns is associated with 
greater asthma risk 
Well studied-strong data 
Mediterranean diet 
High intake of fruits, vegetables and fish are negatively 
associated with asthma risk, better asthma control and fewer 
exacerbations 
Current guidelines- systematic review and meta-analysis 
Curcuma longa Anti-inflammatory properties, therapeutic prospective Experimental data 
Ginger Suspends lung inflammation Experimental data 
   
 
 
Table 3:  The role of various nutrients and diet in COPD 
                          COPD 
 MAIN FINDINGS COMMENTS 
Vitamin A Is negatively related to the presence of COPD Cross-sectional study 
Vitamin C Is related to better lung function Regardless of smoking history 
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Vitamin D 
Vitamin D deficiency has been reported in the COPD population  and 
has been associated with recurrent exacerbations and hospitalization 
Retrospective and cohort study 
Vitamin E 
Low concentrations in lung tissue are related to more severe cases of 
COPD, supplementation demonstrated a reduction in the diagnosis of 
COPD 
Intervention studies are conflicted 
Calcium Intake inversely associated with COPD risk case-control study 
Magnesium Levels are not associated with spirometry values cross-sectional study 
Copper Deficiency results in emphysematous destruction of the lungs Experimental data 
Omega-3 PUFAs 
High dietary intake is inversely associated with COPD risk, improves 
exercise capacity in COPD, may reduce the rate of lung function 
deterioration 
Limited proof 
Probiotics May reduce COPD exacerbations Little literature confirmation 
Fibre 
Consumption has been associated with reduced COPD risk, 
improvement in pulmonary function 
Limited proof 
Mediterranean diet 
Decreased risk of COPD, better pulmonary function, decreased long-
term COPD mortality 
Mainly consumption of fruit, vegetables, fish, and whole 
grains 
Green tea Limits oxidative stress Experimental data 
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